Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
XTL Biopharmaceuticals Announces ADS Ratio Change
XTL Biopharmaceuticals Ltd. announced a change in its American Depositary Shares (ADS) ratio from 1 ADS to 100 ordinary shares, to 1 ADS to 400 ordinary shares, effective March 25, 2026. This change is equivalent to a one-for-four reverse ADS split, meaning existing ADS holders will exchange four ADSs for one new ADS. The company expects a proportional increase in its ADS trading price and states the change will not affect its underlying ordinary shares.